Mersana Therapeutics Files Proxy Statement for 2025 Shareholder Meeting
| Field | Detail |
|---|---|
| Company | Mersana Therapeutics, Inc. |
| Form Type | DEF 14A |
| Filed Date | Apr 29, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: proxy-statement, governance, shareholder-meeting
TL;DR
Mersana's proxy statement is out for the June 12 meeting - vote on directors & pay.
AI Summary
Mersana Therapeutics, Inc. filed its definitive proxy statement (DEF 14A) on April 29, 2025, for its annual meeting on June 12, 2025. The filing outlines the company's governance and proposals to be voted on by shareholders, including the election of directors and executive compensation.
Why It Matters
This filing provides shareholders with crucial information about the company's leadership, compensation practices, and upcoming voting matters, enabling informed participation in corporate governance.
Risk Assessment
Risk Level: low — This is a routine proxy filing, not indicating new material events or significant financial changes.
Key Numbers
- 20250612 — Annual Meeting Date (Shareholders will vote on proposals at this date.)
- 20250429 — Filing Date (The proxy statement was filed on this date.)
Key Players & Entities
- Mersana Therapeutics, Inc. (company) — Registrant
- 0001104659-25-040448 (filing_id) — Accession Number
- 20250429 (date) — Filing Date
- 20250612 (date) — Meeting Date
FAQ
What is the purpose of a DEF 14A filing?
A DEF 14A filing, or definitive proxy statement, is used by companies to solicit shareholder votes on important corporate matters, such as the election of directors and executive compensation.
When is Mersana Therapeutics' annual shareholder meeting scheduled?
Mersana Therapeutics' annual shareholder meeting is scheduled for June 12, 2025.
Who is the filer of this proxy statement?
The filer of this proxy statement is Mersana Therapeutics, Inc.
What is the Accession Number for this filing?
The Accession Number for this filing is 0001104659-25-040448.
What is the Standard Industrial Classification (SIC) code for Mersana Therapeutics?
The Standard Industrial Classification (SIC) code for Mersana Therapeutics is 2834, which corresponds to Pharmaceutical Preparations.
Filing Details
This Form DEF 14A (Form DEF 14A) was filed with the SEC on April 29, 2025 regarding Mersana Therapeutics, Inc..